Health ❯ Pharmaceuticals

Weight Loss

GLP-1 Drugs Medications GLP-1 Medications GLP-1 Agonists Clinical Trials Drug Development Semaglutide Obesity Treatments Obesity Treatment Obesity Drugs Wegovy Medication GLP-1 Generic Drugs Ozempic Novo Nordisk Market Competition Orforglipron Counterfeit Medications Injectable Drugs Prescription Medications Mounjaro Drug Safety Compounded Drugs Counterfeit Drugs Diabetes Treatments GLP-1 Medicines FDA Approvals Prescription Drugs Obesity Management Drug Pricing Anti-Obesity Drugs Incretin Drugs Market Trends GLP-1 Analog Drugs Drug Delivery Systems Addiction Treatment GLP-1 Treatments Eli Lilly Drug Competition GLP Inhibitors Weight Loss Drugs Compounding GLP-1 Receptor Agonists Telehealth Consumer Health Obesity Medications Retatrutide GLP-1 Inhibitors Compounding Pharmacies Injectables Patient Experience Weight Loss Pills Injectable Medications FDA Approval Sibutramine Illicit Drugs Diabetes Treatment Dietary Supplements Tirzepatide Regulatory Issues Demand Trends Childhood Obesity Regulation Drug Efficacy Diabetes Injectable Therapies

GLP-1 Drugs Reshape Obesity Care

High prices, patchy insurance, temporary policy fixes limit patient access to GLP-1 medicines.

Novo Nordisk Asks Court to Halt Lilly’s National GLP‑1 Ads

Samsung Biologics Launches SFr1.46 Billion Cash Bid for PolyPeptide

Generics and Pills Expand Access to GLP‑1s, but Uptake and Coverage Remain Uneven

FuelCell Energy Posts Wider Q2 Loss as Data‑Center Pipeline Surges

India’s Generic Semaglutide Wave Eats Into Mounjaro’s Lead as Novo Holds Share

GLP-1 Drugs Linked to Lower Addiction Risk and Harm in Large VA Study

Novo Nordisk Invests €432 Million to Expand Athlone Plant for Oral GLP-1 Tablets

Lilly Launches FDA-Cleared Monthly Zepbound KwikPen on LillyDirect at $299 Starter Price

AstraZeneca Strikes $1.2 Billion CSPC Pact for Once‑Monthly Obesity and Diabetes Programs

Eli Lilly Picks Lehigh Valley for $3.5 Billion Plant to Make Next-Gen Weight-Loss Drugs

GLP-1 Weight-Loss Push Intensifies as Novo Leads Ads and Wegovy Pill Drives Telehealth Uptake

Trump Cites 'Very Fat' Friend's Ozempic Story to Decry Price Gap

Weight-Loss Pills Could Trim Airline Fuel Costs, Jefferies Says

Strive Compounding Sues Lilly and Novo, Alleging Antitrust Push to Block Compounded GLP-1s

Amazon Pharmacy Adds FDA-Approved Wegovy Pill With $25 Copays and Nationwide Delivery

Nvidia Reportedly Pauses Intel 18A Chip Tests, Knocking Intel Shares

Eli Lilly Picks Huntsville for $6 Billion API Plant to Supply Next-Gen Drugs

Pfizer Licenses Early-Stage Oral GLP-1 From YaoPharma in Up to $2 Billion Deal

Novo Nordisk Slashes Wegovy Price in India by Up to 37% to Take On Mounjaro